Michalina Galas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michalina Galas has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- A. S. Frolova
R.М. Gorbacheva Memorial Institute of Children Oncology, Haematology and Transplantation, I.P. Pavlov Saint-Petersburg First State Medical University, Ministry of Healthcare of Russian Federation
2 shared publications - Boris V. Afanasyev
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of St. Petersburg, Ministry of Health of Russia
2 shared publications - Elena Vladimirovna Semenova
The R.M. Gorbacheva Research Institute for Pediatric Oncology, Hematology and Transplantation of the I.P. Pavlov First Saint Petersburg State Medical University of Ministry of Healthcare of the Russian Federation
2 shared publications - Grzegorz Opolski
1st Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland
2 shared publications - Ildar Munerovich Barkhatov
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of St. Petersburg, Ministry of Health of Russia
2 shared publications - Joanna Raszeja-Wyszomirska
Department of Hepatology, Transplantology and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland
2 shared publications
Latest Publications
- 12 August 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (4)
ASSESSMENT OF BLINATUMOMAB EFFICACY AND SAFETY IN TREATMENT OF RELAPSES AND REFRACTORY FORMS OF B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.
- 12 August 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (4)
ASSESSMENT OF BLINATUMOMAB EFFICACY AND SAFETY IN TREATMENT OF RELAPSES AND REFRACTORY FORMS OF B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.
- Open Access
- 20 September 2018
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 17 (2)
Results of allogeneic hematopoietic stem cell transplantation from haploidentical donors in children and adolescents with high-risk acute leukemia using unmanipulated graft. Ten years experience of R.G.Memorial institute of children oncology, hematology and transplantation. CIC 725
- 20 September 2018
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 17 (2)
Open AccessResults of allogeneic hematopoietic stem cell transplantation from haploidentical donors in children and adolescents with high-risk acute leukemia using unmanipulated graft. Ten years experience of R.G.Memorial institute of children oncology, hematology and transplantation. CIC 725
- Open Access
- 21 August 2018
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 23, 591-597
The Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation
BACKGROUND:Cardiovascular disease (CVD) is an important aggravating factor for orthotopic liver transplantation (OLT) outcomes. CVD still seems to be one of the most common cause of death in the long-term post-transplant period. Nevertheless, there are some limited data regarding the optimal strategy of risk assessment during OLT candidate evaluation. MATERIAL AND METHODS:Routine pre-transplant cardiac workup in 360 patients with end stage liver disease (ESLD) included electrocardiogram, echocardiography, and exercise stress testing. The aim of this retrospective study was an analysis of the impact of cardiovascular risk profile on overall mortality in the 2-year follow-up of 160 patients who underwent liver transplantation. RESULTS:Cardiovascular risk factors or a history of CVD were found in 23.1% of patients who received transplants. The cardiovascular risk factors most common in our group of transplant recipients with ESLD were: diabetes (26.3%), hypertension (25.6%), and hepatopulmonary syndrome (23.1%). Only 3.8% of patients had a positive exercise test. Coronary angiography revealed at least 50% stenosis in some epicardial arteries in 1.9% of patients. The risk of death in long-term follow-up of liver transplant recipients was most strongly associated with 3 cardiac variables: history of coronary artery disease (CAD), angiographically confirmed coronary stenosis, and reduced ejection fraction (EF). CONCLUSIONS:Our study identified pre-transplant CAD with its consequences as a factor associated with increased risk of negative post-transplant outcomes.
- 21 August 2018
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 23, 591-597
Open AccessThe Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation
BACKGROUND:Cardiovascular disease (CVD) is an important aggravating factor for orthotopic liver transplantation (OLT) outcomes. CVD still seems to be one of the most common cause of death in the long-term post-transplant period. Nevertheless, there are some limited data regarding the optimal strategy of risk assessment during OLT candidate evaluation. MATERIAL AND METHODS:Routine pre-transplant cardiac workup in 360 patients with end stage liver disease (ESLD) included electrocardiogram, echocardiography, and exercise stress testing. The aim of this retrospective study was an analysis of the impact of cardiovascular risk profile on overall mortality in the 2-year follow-up of 160 patients who underwent liver transplantation. RESULTS:Cardiovascular risk factors or a history of CVD were found in 23.1% of patients who received transplants. The cardiovascular risk factors most common in our group of transplant recipients with ESLD were: diabetes (26.3%), hypertension (25.6%), and hepatopulmonary syndrome (23.1%). Only 3.8% of patients had a positive exercise test. Coronary angiography revealed at least 50% stenosis in some epicardial arteries in 1.9% of patients. The risk of death in long-term follow-up of liver transplant recipients was most strongly associated with 3 cardiac variables: history of coronary artery disease (CAD), angiographically confirmed coronary stenosis, and reduced ejection fraction (EF). CONCLUSIONS:Our study identified pre-transplant CAD with its consequences as a factor associated with increased risk of negative post-transplant outcomes.
- 14 March 2018
- Published by Elsevier in Transplantation Proceedings
- Vol. 50 (7) , 2022-2026
Troponin I Is Not a Predictor of Early Cardiovascular Morbidity in Liver Transplant Recipients
- 14 March 2018
- Published by Elsevier in Transplantation Proceedings
- Vol. 50 (7) , 2022-2026
Troponin I Is Not a Predictor of Early Cardiovascular Morbidity in Liver Transplant Recipients